Cure My Disease

Don't miss your cure!

 Log in / Sign up

A bracelet and a blood pressure cuff: a simple plan to protect new mothers at risk

NCT ID NCT07807098

Disease control Sponsor: Memorial Hermann Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This pilot study tests whether giving new mothers with preeclampsia or gestational hypertension a blood pressure cuff, extra education, and a reminder bracelet helps them manage their blood pressure at home. About 40 participants will receive these tools before leaving the hospital and will be interviewed at 6 and 10 weeks after discharge. The goal is to see if these low-cost aids improve self-monitoring, knowledge, and confidence, and to inform a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A combination of standard discharge education, a home blood pressure cuff, and an 'At-Risk Postpartum' bracelet
What this could lead to
If this works, it could point toward a simple, low-cost way to help new mothers with preeclampsia or gestational hypertension monitor their blood pressure at home and stay safer after discharge.
What could go wrong
This is a small pilot study with only 40 participants, so the results may not apply to everyone. It relies on self-reported interviews, and the tools may not change behavior or outcomes as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: -A new diagnosis of GHTN or PE, who are discharged from FLC, and express willingness to participate in virtual interviews. Exclusion Criteria: * Patients with a preexisting diagnosis of chronic hypertension or PE, or are currently on antihypertensive medications (as these factors may influence self-management behaviors and outcomes).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gestational hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced preeclampsia puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gestational hypertension Postpartum Preeclampsia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.